ROBERT GROSSMAN: Open Payments
NPI 1639302789 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,665 in 112 payments from 21 companies in 2025. Trend: 2023 $1,715 · 2024 $2,855 · 2025 $2,665
Food & beverage: $2,665
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $400 |
| Inspire Medical Systems, Inc. | 5 | $366 |
| AstraZeneca Pharmaceuticals LP | 13 | $230 |
| GENZYME CORPORATION | 11 | $216 |
| Mallinckrodt Hospital Products Inc. | 7 | $204 |
| United Therapeutics Corporation | 6 | $176 |
| Electromed, Inc. | 4 | $144 |
| Regeneron Healthcare Solutions, Inc. | 12 | $136 |
| ANI Pharmaceuticals, Inc. | 4 | $121 |
| Viatris Specialty LLC | 5 | $117 |
Products named: INSPIRE, DUPIXENT, NUCALA, ACTHAR, Tyvaso, TRELEGY ELLIPTA, SMARTVEST, PURIFIED CORTROPHIN GEL.
Industry payments across VA — which companies pay providers there.
